A carregar...
Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology
Despite their considerable advantages, many circulating biomarkers have well-documented limitations. One prominent shortcoming in oncology is a high frequency of false-positive indications for malignant disease in upfront diagnosis. Because one common cause of false positivism is biomarker productio...
Na minha lista:
| Publicado no: | J Nucl Med |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4274751/ https://ncbi.nlm.nih.gov/pubmed/24029655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.113.119867 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|